Viskase Holdings, Inc.
ENZN, ENZND · Biological Products, (No Diagnostic Substances) · 14.3M shares · +10%/yr ↑ dilution · EDGAR filings ↗
Net buyback after stock comp: $121M (gross $121M, SBC -$205K)
Grade
D48Food-casings/holding company with a net loss and negative equity; unusual balance-sheet structure.
Strengths
- Very high reported liquidity — current ratio 58.6 (99th) — cash/holding structure
Risks
- Net loss — ROA -8%
- Negative equity — ROE 135% is an artifact
- Opaque holding structure lowers confidence — per 10-K
Notable findings
- Restatement, although pursuant to the rules of the OTCQB, Enzon is required to re-apply to the OTCQB following such change of control transaction The Merger Agreement and the transactions contemplated thereby, 8-K ↗
- Exec changeRecent 8-K item 5.02 8-K ↗
- Auditor changeRecent 8-K item 4.01 8-K ↗
- Chronic dilutionShare count +10%/yr over 4y (dilution, book value/share -136%)
- Pending mergerAs noted above, we have entered into the Merger Agreement with Viskase and our stockholders have approved the Reverse Stock Split Proposal and the Merger Proposal
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Return on equity
135.0%
Return on assets
-8.0%
Revenue growth (QoQ)
-8.1%
Net-income growth
-538.2%
Current ratio
58.6×
Tangible book value
-$3M
Cash & investments
$43M
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-26 | ICAHN CARL C | Grant | 7.4M | — |
| 2026-03-25 | ICAHN CARL C | Disposition | 39K | — |
| 2026-03-25 | ICAHN CARL C | Grant | 5.7M | — |
All non-derivative Form 4 activity (SEC), newest first.
Supply chain
Customers (2)
Suppliers (0)
Named in the 10-K; linked when we track them.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-05-05 | Material agreement3.035.03Reg FDExhibits | filing ↗ |
| 2026-05-01 | Exec/director change | filing ↗ |
| 2026-05-01 | Exhibits | filing ↗ |
| 2026-04-21 | Material agreementDebt obligationExhibits | filing ↗ |
| 2026-04-16 | Auditor changeExhibits | filing ↗ |
| 2026-04-15 | Exec/director change | filing ↗ |
| 2026-03-26 | Acquisition/disposition3.025.01Exec/director change5.03Reg FDExhibits | filing ↗ |
| 2026-03-25 | Reg FDExhibits | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-05-05 | 2026-04-30 | 0001104659-26-055632 ↗ |
| 10-Q | 2026-05-04 | 2026-03-31 | 0001104659-26-054911 ↗ |
| 8-K/A | 2026-05-01 | 2026-03-26 | 0001104659-26-053523 ↗ |
| 8-K | 2026-05-01 | 2026-04-29 | 0001104659-26-053522 ↗ |
| 10-K/A | 2026-04-29 | 2025-12-31 | 0001104659-26-051643 ↗ |
| 8-K | 2026-04-21 | 2026-04-16 | 0001104659-26-046064 ↗ |
| 8-K | 2026-04-16 | 2026-04-14 | 0001104659-26-044420 ↗ |
| 8-K | 2026-04-15 | 2026-04-10 | 0001104659-26-043811 ↗ |
| 8-K | 2026-03-26 | 2026-03-26 | 0001104659-26-035301 ↗ |
| 8-K | 2026-03-25 | 2026-03-25 | 0001104659-26-034187 ↗ |
| 8-K | 2026-03-24 | 2026-03-20 | 0001104659-26-033624 ↗ |
| 8-K | 2026-03-19 | 2026-03-19 | 0001104659-26-032092 ↗ |